Metropolis Healthcare Limited has informed the Exchange about change in Senior Management Personnel
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare Limited's Board meeting on May 13, 2026 approved multiple items including audited FY2026 financial results showing standalone profit after tax of Rs 15,748.33 Lakhs and consolidated profit after tax of Rs 19,118.20 Lakhs. The company declared a 2nd interim dividend of Rs 1 per share with record date May 19, 2026. Key management change: Dr. Nilesh Shah transitions from President - Internal Assurance (full-time role) to an advisory role effective May 14, 2026, and will cease to be classified as Senior Management Personnel from close of business on May 13, 2026. The board also approved appointment of Deloitte Haskins & Sells as new statutory auditors replacing B S R & Co. LLP for 5 years subject to shareholder approval.
The senior management transition of Dr. Nilesh Shah represents a change in key management personnel structure. The company delivered strong FY2026 financials with ~26% YoY growth in consolidated profit. Dividend declaration signals continued shareholder returns despite management changes.